Form 8-K - Current report:
SEC Accession No. 0001641172-25-002862
Filing Date
2025-04-07
Accepted
2025-04-04 18:09:38
Documents
14
Period of Report
2025-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 72719
2 ex10-1.htm EX-10.1 9146
  Complete submission text file 0001641172-25-002862.txt   263594

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE aneb-20250404.xsd EX-101.SCH 3012
4 XBRL LABEL FILE aneb-20250404_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE aneb-20250404_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4008
Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734
Business Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40388 | Film No.: 25816021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)